Rohit M. Oemrawsingh
Papers
1
Total Citations
157
H-Index
1
About
Rohit M. Oemrawsingh is a leading cardiovascular researcher whose work bridges lipidomics and clinical cardiology to improve risk prediction in coronary artery disease (CAD). His primary research areas include molecular lipid species, ceramide biomarkers, and long-term cardiovascular outcomes. Oemrawsingh’s major contribution lies in identifying that specific plasma lipid molecules and ceramide ratios can predict major adverse cardiac events (MACEs) years in advance, offering a more precise tool than traditional cholesterol metrics. His landmark 2018 study, cited 157 times, followed 581 CAD patients for a median of 4.7 years, demonstrating that these lipid signatures independently forecast clinical trajectories. This work has reshaped how clinicians assess residual risk in patients already on statin therapy, moving beyond LDL cholesterol alone. Oemrawsingh’s research is widely recognized for its translational impact, earning citations from cardiology and metabolomics communities alike. By translating complex lipidomic data into actionable prognostic markers, he has advanced personalized medicine in cardiovascular care, making his findings essential reading for students and researchers seeking to understand the next frontier in heart disease prevention.
Research Focus
Key Achievements
Top Papers
- 1